Global HIV Vaccine Enterprise
The HIV model created by Visual Science appeared on the cover of the special issue of Nature Medicine (September 8, 2010) prepared by the Global HIV Vaccine Enterprise. In this publication, the Enterprise published the strategic research plan to accelerate the development of vaccines against HIV (the “2010 Plan”). The 2010 Plan was developed by the Council of the Global HIV Vaccine Enterprise with the participation of hundreds of scientists, policy-makers, funders, and advocates worldwide.
The model also appeared on the cover of the International AIDS Vaccine Initiative (IAVI) Report. It is an authoritative guide that publishes information about all events and innovations, concerning the development of the vaccine against HIV. The IAVI report is published 6 times a year and its audience is represented by specialists in more than 130 countries. The mission of the InternationalAIDS Vaccine Initiative is to ensure the development of safe, effective, accessible, preventive HIV vaccines for use throughout the world. IAVI participates in research and development of candidate vaccines, addressing the legal issues concerning HIV and AIDS, supporting developing countries. The IAVI Innovation Fund is supported by the Bill and Melinda Gates Foundation. IAVI has representative offices in Africa, Europe, India, and the US.
In addition, our HIV model has been included in Stanley Plotkin’s Vaccines, a textbook hailed as the “Bible of vaccinologists” by The Lancet; featured in presentations by the Nobel Prize-winning virologist Françoise Barré-Sinoussi; and covered by The New York Times, National Geographic, Wired, Popular Science, and other popular periodicals.
The Visual Science team demonstrated high level of professionalism and creativity. They successfully set the priorities and rapidly reacted to remarks. All the work was finished on time. We recommend this company to everybody.